Achieve Life Sciences, Inc. Tax Withholding Paid on Stock Awards
Achieve Life Sciences, Inc. (ACHV) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-03-24
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-12-31 was $0.00.
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-09-30 was $0.00.
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-12-31 was $0.00.
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-09-30 was $0.00.
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $114.00K, a 48.18% decline from fiscal 2023.
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $220.00K, a 368.09% increase from fiscal 2022.
- Achieve Life Sciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $47.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-24 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $114.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $114.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $114.00K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $220.00K 10-K · filed 2026-03-24 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $220.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $220.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $47.00K 10-K · filed 2025-03-11 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $47.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $47.00K 10-Q · filed 2023-08-14 | |||
| 2017-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$17.00K derived: sum of 2 quarters · filed 2020-03-13 | -$14.00K derived: sum of 3 quarters · filed 2020-03-13 | $5.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $3.00K derived: sum of 2 quarters · filed 2018-11-07 | $22.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $22.00K 10-Q · filed 2017-07-31 | ||
| 2017-03-31 | $19.00K 10-Q · filed 2017-05-15 | |||
| 2016-12-31 | $2.00K 10-K · filed 2017-02-23 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $52.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $52.00K 10-Q · filed 2016-11-10 | $53.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $52.00K 10-Q · filed 2016-08-04 | $53.00K derived: sum of 3 quarters · filed 2017-02-23 | |
| 2015-03-31 | $52.00K 10-Q · filed 2016-05-12 | $53.00K derived: sum of 2 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $29.00K 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $28.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |